Research study Program year 2025 Source: CMS Open Payments

Msb-Dr004

Research payments

$3,709,997

286 payments

Through program year 2025, $3,709,997 in research payments was reported against Msb-Dr004, across 286 payments, paid by Mesoblast, Inc..

Paid by: Mesoblast, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$3,709,997	286

Breakdown

Who paid Research payments · program year 2025

Mesoblast, Inc. $3,709,997 286 payments

Who received the money Research payments · program year 2025

Conquest Research Organisation paid for research $669,345 12 payments
Solaris Research Institute Inc. Organisation paid for research $453,166 13 payments
Formoso Pain Specialists, Pa Organisation paid for research $175,166 12 payments
Meta Medical Research Institute, Llc Organisation paid for research $157,869 12 payments
Vista Clinical Research Organisation paid for research $143,429 5 payments
Iqra Research Llc Organisation paid for research $141,844 11 payments
Axsendo Clinical Research, LLC Organisation paid for research $119,645 6 payments
Source Healthcare, Llc Organisation paid for research $119,086 12 payments
Virginia Ispine Physicians, Pc Organisation paid for research $117,257 10 payments
University of Kansas Medical Center Research Institute, Inc Organisation paid for research $115,112 10 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.